Caxton Advantage Life Sciences Fund is a venture capital and private equity firm investing in companies operating in the life science industry that is headquartered in New York City, New York.
Investments
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.
Timeline
Funded Companies
Company
Industry
Website
Location
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Venture Capital Firm attributes
Invested in
